Correction to: Breast Cancer Res
https://doi.org/10.1186/s13058-020-1247-4
Anzeige
After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.
The correction version of Table 2 is shown below.
Table 2
Characteristics of cohort of BRCA1 and BRCA2 mutation carriers
BRCA1 mutation carriers | BRCA2 mutation carriers | |||
|---|---|---|---|---|
Unaffected women (N = 2003) | Women with breast cancer (N = 269) | Unaffected women (N = 1448) | Women with breast cancer (N = 157) | |
Total Person-years of follow-up | 11,207 | 1134 | 7286 | 600 |
Person-years of follow-up (mean (sd)) | 5.60 (3.67) | 4.21 (3.27) | 5.03 (3.44) | 3.82 (3.08) |
Age at start of follow-up (mean (sd)) | 37.51 (11.80) | 40.68 (10.25) | 40.00 (12.53) | 45.14 (10.11) |
Age at diagnosis/censoring (mean (sd)) | 43.10 (12.28) | 44.90 (10.33) | 45.00 (13.00) | 48.97 (10.30) |
Reason for censoring | ||||
Breast cancer | 0 | 269 | 0 | 157 |
Ovarian cancer | 49 | 3a | 9 | 1a |
Other cancer | 45 | 5a | 28 | 2a |
RRM | 299 | – | 181 | – |
Death | 5 | – | 8 | – |
Unaffected at last follow-up time | 1605 | – | 1222 | – |
Year of birth | ||||
< =1960 | 604 (83.54) | 119 (16.46) | 500 (84.75) | 90 (15.25) |
> 1960 | 1399 (90.32) | 150 (9.68) | 948 (93.40) | 67 (6.60) |
Menopausal status | ||||
Premenopausal at censoringb | ||||
Last informationc after censoring | 512 | 69 | 344 | 35 |
Last information before censoringd | 585 | 58 | 473 | 35 |
Postmenopausal | ||||
Natural menopause age known | 194 | 27 | 182 | 31 |
Natural menopause age unknown | 5 | 0 | 7 | 1 |
Post hysterectomy | 70 | 12 | 64 | 11 |
Unknown menopausal status | 62 | 13 | 33 | 8 |
RRSO status at censoring | ||||
No RRSO | ||||
Last information after censoring | 664 | 110 | 467 | 79 |
Last information before censoring | 618 | 44 | 535 | 27 |
RRSO | 721 | 115 | 446 | 51 |
As reason for menopausee | 574 | 90 | 345 | 36 |
After natural menopause | 101 | 18 | 76 | 10 |
After hysterectomy | 46 | 7 | 25 | 5 |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.